Last updated on February 2019

STOPPER CHINA:With Tandem Microspheres in the Treatment of Localized Hepatocellular Carcinoma


Brief description of study

A Single-arm Trial of Transcatheter Arterial Chemoembolization with Tandem Microspheres in the Treatment of Localized Hepatocellular Carcinoma

Detailed Study Description

It is a prospective, single-arm, multicenter study. The primary effectiveness endpoint for this clinical trial is 6-month overall objective tumor response (ORR).

Clinical Study Identifier: NCT03113955

Find a site near you

Start Over